State of Biopharma R&D 2026: 7 Numbers Every Sponsor Should Know   Biopharma enters the second half of 2026 with no shortage of innovation.  New modalities are advancing.   Emerging biotech is responsible for an increasing share of clinical development.  Artificial intelligence is moving from experimentation into R&D workflows.   And dozens of novel medicines continue to reach patients every year.  Yet the economics and execution of drug development Read more
Clinical Research Focus. 57th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of July 2026. Read more
The Obesity Drug Race: Who Can Challenge Lilly and Novo? Obesity has become one of the biggest opportunities in drug development. By 2035, an estimated 1.53 billion adults globally are projected to be living with obesity. When overweight is included, the number could reach 3.3 billion, or more than half of the world’s adult population. The economic impact could exceed $4 trillion annually. The pharmaceutical Read more
China Built an AI-Agent Eye Clinic. Here Is What Happened in the Real World AI is already widely used in medical imaging and diagnostic support, but most systems still perform individual tasks within a traditional clinical workflow. Researchers at Tsinghua University in China wanted to test a more ambitious model: a clinic where multiple AI agents support patients across the entire care journey. The result was the AI-Agent Augmented Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us